Navigation Links
PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
Date:11/6/2007

d by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "may"; "should"; "could"; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risks associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of Valortim in humans, timely and successful development of an efficient and scalable manufacturing process, unexpected funding delays by NIAID/BARDA, unforeseen safety issues resulting from the handling of Bacillus anthracis, as well as risks detailed from time to time in PharmAthene's public disclosure filings with the U.S. Securities and Exchange Commission (the "SEC"). There can be no assurance that such development efforts will succeed or that other developed products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success. Copies of PharmAthene's public disclosure filings are available from its investor relations department.

For Medarex: Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "suggest"; "may"; "should"; "could"; or similar statements are forward-looking statements. Medarex disclaims, however, any intent or obligation to update these forward-looking statements, except as required by l
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. PharmAthene to Present at the Rodman and Renshaw/Acumen BioFin 9th Annual Healthcare Conference
2. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
3. Medarex to Present at the JPMorgan Small/Mid Cap Conference
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... New Jersey (PRWEB) April 25, 2015 ... people aged twelve and above needed treatment for an ... according to the Substance Abuse and Mental Health Services ... September 2011). Beyond these alarming numbers are harrowing stories ... by substance abuse . David H. Kerr ...
(Date:4/25/2015)... Henderson, NV (PRWEB) April 25, 2015 ... Program is still eliciting the excitement of the public ... well into the months of May and June. ... Wellness™ held their biannual tradition of "Special Prayers." More ... who had attended previous Special Prayers and have reported ...
(Date:4/25/2015)... New York New York (PRWEB) April 25, 2015 ... announce that Dr. Jerry Blaivas has been chosen by the ... Award for his contributions to medicine in the field of ... as the best in his speciality, Genito-Urinary diseases. He ... medicine, specifically in the field of urology. Not only ...
(Date:4/24/2015)... Bird B Gone, the leader in bird ... a complete line of bird control solutions to address the ... Flu Strains Threaten Pacific, Central and Mississippi Farms , According ... a number of highly pathogenic avian flus in the Pacific, ... spread when wild birds enter poultry farms. The USDA urges ...
(Date:4/24/2015)... 24, 2015 Ryadon is a leading ... of capabilities and services to complement any custom hardware ... Discount Program will be offered on all heavy duty ... 4-19: Receive 10% discount - Order 20+: Receive 20% ... Drawer Slides Products, Furniture ...
Breaking Medicine News(10 mins):Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3Health News:Trivedi Master Wellness™ Announces the Resounding Success of their Special Prayers Human Wellness Program 2Health News:Trivedi Master Wellness™ Announces the Resounding Success of their Special Prayers Human Wellness Program 3Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3
... the third of five papers in the PLoS Medicine ... Africa, Sara Bennett and Freddie Ssengooba this week discuss the ... from Johns Hopkins University in Baltimore USA, and Dr Ssengooba ... basis for improving maternal, newborn, and child health (MNCH) in ...
... induce specific epigenetic changes and gene mutations that may be ... online study published June 29 in the Journal of ... a risk factor for colorectal cancer, with a recent meta-analysis ... past are 18% more likely to develop colorectal cancer than ...
... TUESDAY, June 29 (HealthDay News) -- Intensive control of ... disease for those with long-term type 2 diabetes who are ... it may have some other benefits, a new analysis suggests. ... a certain group of patients may slow progression of eye ...
... ... for employers who want to provide health benefits and control costs., , ... Minneapolis, MN (PRWEB) June 29, ... the largest independent insurance and employee benefits brokers in the Midwest, to offer customized ...
... use has decreased drastically over the last few decades, we ... Physicians (ACP) President, J. Fred Ralston, Jr., MD, FACP, said ... In Tobacco Control and Prevention, ACP called for a comprehensive ... actions being taken by states currently. "A comprehensive tobacco ...
... Ohio State University Comprehensive Cancer Center-Arthur G. James ... (OSUCCC-James) have discovered how a substance that is ... block the proliferation of cancer cells. Compelling ... have anticancer effects and other health benefits, the ...
Cached Medicine News:Health News:Smoking-related colorectal cancer in older women is associated with molecularly-defined DNA changes 2Health News:Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk 2Health News:Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk 3Health News:Bloom Health and Christensen Group Partner Together to Deliver Innovative Solution 2Health News:Internists outline comprehensive federal strategy to control tobacco use 2Health News:Study shows how dietary supplement may block cancer cells 2
(Date:4/24/2015)... 24, 2015 Research and Markets ( ... "Global Biobanking Market 2015-2019" report to their offering. ... to grow at a CAGR of 7.07% over the ... be divided into two segments: Equipment and Consumables. This ... of the Global Biobanking market for the period 2015-2019. ...
(Date:4/24/2015)... -- Introduction of new "Elements" ... for radiosurgery/SBRT   The "Elements" strategy ... the workflow for difficult to treat indications in ... comes full circle with the introduction of automated ... enable on-the-fly generation of consistent treatment plans for ...
(Date:4/24/2015)... April 24, 2015 The National Institute ... the National Institutes of Health [NIH])  provided grants ... projects for the development of diagnostic tests for ... outbreaks at U.S. health facilities , the NIAID ... rapid, multiplexed and effective tests using alternative methods ...
Breaking Medicine Technology:Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4
... CMW, Inc. began working together in ... for orthopaedic applications. Today, backed up ... and excellence in cemented total hip ... first proven bone cements known to ...
... For over 35 years, Palacos ... itself as the gold standard ... since the introduction of,the Optivac ... combination has provided thousands of ...
... for ocular precision tonometry. ,The PASCAL Dynamic ... contact tonometer for ophthalmological applications. The slitlamp-mounted ... pressure (IOP) and of ocular pulse amplitude ... few seconds. It measures pulsatile IOP directly ...
Occu-Flo Plugs Offer: , Easy Insertion , A polished, smooth, transparent finish which creates immediate patient comfort and adaptation , High tolerance by patients , No discomfort should removal be ...
Medicine Products: